Primary Open-Angle Glaucoma Preferred Practice Pattern®

Published:November 12, 2020DOI:https://doi.org/10.1016/j.ophtha.2020.10.022
      Primary Open-Angle Glaucoma Preferred Practice Pattern®
      To read this article in full you will need to make a payment
      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Scottish Intercollegiate Guidelines Network
        Annex B: Key to evidence statements and grades of recommendations. SIGN 50: A guideline developer's handbook.
        2008 edition, revised 2011. SIGN, Edinburgh2015 (SIGN publication no. 50)
        Available at: www.sign.ac.uk
        Date accessed: November , 2020
        • Guyatt GH
        • Oxman AD
        • Vist GE
        • et al.
        GRADE: An emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • GRADE working group
        Organizations that have endorsed or that are using GRADE.
        Available at: www.gradeworkinggroup.org/
        Date accessed: November , 2020
        • Jonas JB
        • Budde WM
        • Panda-Jonas S
        Ophthalmoscopic evaluation of the optic nerve head.
        Surv Ophthalmol. 1999; 43: 293-320
        • Morgan JE
        • Bourtsoukli I
        • Rajkumar KN
        • et al.
        The accuracy of the inferior>superior>nasal>temporal neuroretinal rim area rule for diagnosing glaucomatous optic disc damage.
        Ophthalmology. 2012; 119: 723-730
        • Foster PJ
        • Buhrmann R
        • Quigley HA
        • Johnson GJ
        The definition and classification of glaucoma in prevalence surveys.
        Br J Ophthalmol. 2002; 86: 238-242
        • Dielemans I
        • Vingerling JR
        • Wolfs RC
        • et al.
        The prevalence of primary open-angle glaucoma in a population-based study in the Netherlands: The Rotterdam study.
        Ophthalmology. 1994; 101: 1851-1855
        • Kass MA
        • Heuer DK
        • Higginbotham EJ
        • et al.
        The ocular hypertension treatment study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
        Arch Ophthalmol. 2002; 120 (discussion 829-730.): 701-713
        • Kapetanakis VV
        • Chan MP
        • Foster PJ
        • et al.
        Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): A systematic review and meta-analysis.
        Br J Ophthalmol. 2016; 100: 86-93
        • Tham YC
        • Li X
        • Wong TY
        • et al.
        Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis.
        Ophthalmology. 2014; 121: 2081-2090
        • Quigley HA
        • Broman AT
        The number of people with glaucoma worldwide in 2010 and 2020.
        Br J Ophthalmol. 2006; 90: 262-267
        • Klein BE
        • Klein R
        Projected prevalences of age-related eye diseases.
        Invest Ophthalmol Vis Sci. 2013; 54: ORSF14-ORSF17
        • Vajaranant TS
        • Wu S
        • Torres M
        • Varma R
        The changing face of primary open-angle glaucoma in the United States: Demographic and geographic changes from 2011 to 2050.
        Am J Ophthalmol. 2012; 154: 303-314
        • Friedman DS
        • Wolfs RC
        • O'Colmain BJ
        • et al.
        Eye diseases prevalence research group. Prevalence of open-angle glaucoma among adults in the United States.
        Arch Ophthalmol. 2004; 122: 532-538
        • Sommer A
        • Tielsch JM
        • Katz J
        • et al.
        Racial differences in the cause-specific prevalence of blindness in East Baltimore.
        N Engl J Med. 1991; 325: 1412-1417
        • Varma R
        • Ying-Lai M
        • Francis BA
        • et al.
        Los Angeles Latino eye study group. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: The Los Angeles Latino eye study.
        Ophthalmology. 2004; 111: 1439-1448
        • Stein JD
        • Kim DS
        • Niziol LM
        • et al.
        Differences in rates of glaucoma among Asian Americans and other racial groups, and among various Asian ethnic groups.
        Ophthalmology. 2011; 118: 1031-1037
        • Tielsch JM
        • Sommer A
        • Katz J
        • et al.
        Racial variations in the prevalence of primary open-angle glaucoma: The Baltimore eye survey.
        JAMA. 1991; 266: 369-374
        • Leske MC
        • Connell AM
        • Schachat AP
        • Hyman L
        The Barbados eye study: Prevalence of open angle glaucoma.
        Arch Ophthalmol. 1994; 112: 821-829
        • Quigley HA
        • West SK
        • Rodriguez J
        • et al.
        The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto ver.
        Arch Ophthalmol. 2001; 119: 1819-1826
        • Mitchell P
        • Smith W
        • Attebo K
        • Healey PR
        Prevalence of open-angle glaucoma in Australia: The Blue Mountains eye study.
        Ophthalmology. 1996; 103: 1661-1669
        • Wensor MD
        • McCarty CA
        • Stanislavsky YL
        • et al.
        The prevalence of glaucoma in the Melbourne visual impairment project.
        Ophthalmology. 1998; 105: 733-739
        • Klein BE
        • Klein R
        • Sponsel WE
        • et al.
        Prevalence of glaucoma: The Beaver Dam eye study.
        Ophthalmology. 1992; 99: 1499-1504
        • Coffey M
        • Reidy A
        • Wormald R
        • et al.
        Prevalence of glaucoma in the west of Ireland.
        Br J Ophthalmol. 1993; 77: 17-21
        • Gordon MO
        • Beiser JA
        • Brandt JD
        • et al.
        The ocular hypertension treatment study: Baseline factors that predict the onset of primary open-angle glaucoma.
        Arch Ophthalmol. 2002; 120 (discussion 829-730.): 714-720
        • Sommer A
        • Tielsch JM
        • Katz J
        • et al.
        Relationship between intraocular pressure and primary open angle glaucoma among White and Black Americans: The Baltimore eye survey.
        Arch Ophthalmol. 1991; 109: 1090-1095
        • Leske MC
        • Connell AM
        • Wu SY
        • et al.
        Barbados eye studies group. Incidence of open-angle glaucoma: The Barbados eye studies.
        Arch Ophthalmol. 2001; 119: 89-95
        • Le A
        • Mukesh BN
        • McCarty CA
        • Taylor HR
        Risk factors associated with the incidence of open-angle glaucoma: The visual impairment project.
        Invest Ophthalmol Vis Sci. 2003; 44: 3783-3789
        • Leibowitz HM
        • Krueger DE
        • Maunder LR
        • et al.
        The Framingham eye study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.
        Surv Ophthalmol. 1980; 24: 335-610
        • Miglior S
        • Pfeiffer N
        • Torri V
        • et al.
        European glaucoma prevention study (EGPS) group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European glaucoma prevention study.
        Ophthalmology. 2007; 114: 3-9
        • Kim KE
        • Kim MJ
        • Park KH
        • et al.
        Prevalence, awareness, and risk factors of primary open-angle glaucoma: Korea national health and nutrition examination survey 2008-2011.
        Ophthalmology. 2016; 123: 532-541
        • Pan CW
        • Yang WY
        • Hu DN
        • et al.
        Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese.
        Am J Ophthalmol. 2017; 176: 127-133
        • Armaly MF
        • Krueger DE
        • Maunder L
        • et al.
        Biostatistical analysis of the collaborative glaucoma study: I. Summary report of the risk factors for glaucomatous visual-field defects.
        Arch Ophthalmol. 1980; 98: 2163-2171
        • Mason RP
        • Kosoko O
        • Wilson MR
        • et al.
        National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings.
        Ophthalmology. 1989; 96: 1363-1368
        • Leske MC
        • Wu SY
        • Hennis A
        • et al.
        Bess study group. Risk factors for incident open-angle glaucoma: The Barbados eye studies.
        Ophthalmology. 2008; 115: 85-93
        • Chiam N
        • Baskaran M
        • Li Z
        • et al.
        Social, health and ocular factors associated with primary open-angle glaucoma amongst Chinese Singaporeans.
        Clin Exp Ophthalmol. 2018; 46: 25-34
        • Karti O
        • Yuksel B
        • Uzunel UD
        • et al.
        The assessment of optical coherence tomographic parameters in subjects with a positive family history of glaucoma.
        Clin Exp Optom. 2017; 100: 663-667
        • Brandt JD
        • Beiser JA
        • Kass MA
        • Gordon MO
        Central corneal thickness in the ocular hypertension treatment study (OHTS).
        Ophthalmology. 2001; 108: 1779-1788
        • Tielsch JM
        • Katz J
        • Sommer A
        • et al.
        Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment.
        Arch Ophthalmol. 1995; 113: 216-221
        • Leske MC
        • Connell AM
        • Wu SY
        • et al.
        Risk factors for open-angle glaucoma. The Barbados eye study.
        Arch Ophthalmol. 1995; 113: 918-924
        • Tham YC
        • Lim SH
        • Gupta P
        • et al.
        Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: The Singapore epidemiology of eye diseases study.
        Br J Ophthalmol. 2018; 102: 1402-1406
        • Mitchell P
        • Smith W
        • Chey T
        • Healey PR
        Open-angle glaucoma and diabetes: The Blue Mountains eye study, Australia.
        Ophthalmology. 1997; 104: 712-718
        • Chopra V
        • Varma R
        • Francis BA
        • et al.
        Los Angeles Latino eye study group. Type 2 diabetes mellitus and the risk of open-angle glaucoma: The Los Angeles Latino eye study.
        Ophthalmology. 2008; 115: 227-232
        • Bonovas S
        • Peponis V
        • Filioussi K
        Diabetes mellitus as a risk factor for primary open-angle glaucoma: A meta-analysis.
        Diabet Med. 2004; 21: 609-614
        • Zhao D
        • Cho J
        • Kim MH
        • et al.
        Diabetes, fasting glucose, and the risk of glaucoma: A meta-analysis.
        Ophthalmology. 2015; 122: 72-78
        • Mitchell P
        • Hourihan F
        • Sandbach J
        • Wang JJ
        The relationship between glaucoma and myopia: The Blue Mountains eye study.
        Ophthalmology. 1999; 106: 2010-2015
        • Grodum K
        • Heijl A
        • Bengtsson B
        Refractive error and glaucoma.
        Acta Ophthalmol Scand. 2001; 79: 560-566
        • Xu L
        • Wang Y
        • Wang S
        • Jonas JB
        High myopia and glaucoma susceptibility the Beijing eye study.
        Ophthalmology. 2007; 114: 216-220
        • Shen L
        • Melles RB
        • Metlapally R
        • et al.
        The association of refractive error with glaucoma in a multiethnic population.
        Ophthalmology. 2016; 123: 92-101
        • Drance SM
        • Fairclough M
        • Butler DM
        • Kottler MS
        The importance of disc hemorrhage in the prognosis of chronic open angle glaucoma.
        Arch Ophthalmol. 1977; 95: 226-228
        • Diehl DL
        • Quigley HA
        • Miller NR
        • et al.
        Prevalence and significance of optic disc hemorrhage in a longitudinal study of glaucoma.
        Arch Ophthalmol. 1990; 108: 545-550
        • Airaksinen PJ
        • Mustonen E
        • Alanko HI
        Optic disc haemorrhages precede retinal nerve fibre layer defects in ocular hypertension.
        Acta Ophthalmol (Copenh). 1981; 59: 627-641
        • Siegner SW
        • Netland PA
        Optic disc hemorrhages and progression of glaucoma.
        Ophthalmology. 1996; 103: 1014-1024
        • Budenz DL
        • Anderson DR
        • Feuer WJ
        • et al.
        Ocular hypertension treatment study group. Detection and prognostic significance of optic disc hemorrhages during the ocular hypertension treatment study.
        Ophthalmology. 2006; 113: 2137-2143
        • Gordon MO
        • Torri V
        • Miglior S
        • et al.
        Ocular hypertension treatment study group, European glaucoma prevention study group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
        Ophthalmology. 2007; 114: 10-19
        • Wang S
        • Liu Y
        • Zheng G
        Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis.
        PLoS One. 2017; 12e0186634
        • Broadway DC
        • Drance SM
        Glaucoma and vasospasm.
        Br J Ophthalmol. 1998; 82: 862-870
        • Cursiefen C
        • Wisse M
        • Cursiefen S
        • et al.
        Migraine and tension headache in high-pressure and normal-pressure glaucoma.
        Am J Ophthalmol. 2000; 129: 102-104
        • Fan YY
        • Su WW
        • Liu CH
        • et al.
        Correlation between structural progression in glaucoma and obstructive sleep apnea.
        Eye (Lond). 2019; 33: 1459-1465
        • Kuzin AA
        • Varma R
        • Reddy HS
        • et al.
        Ocular biometry and open-angle glaucoma: The Los Angeles Latino eye study.
        Ophthalmology. 2010; 117: 1713-1719
        • Wang J
        • Mitchell P
        • Smith W
        Is there an association between migraine headache and open-angle glaucoma?: Findings from the Blue Mountains eye study.
        Ophthalmology. 1997; 104: 1714-1719
        • Susanna CN
        • Diniz-Filho A
        • Daga FB
        • et al.
        A prospective longitudinal study to investigate corneal hysteresis as a risk factor for predicting development of glaucoma.
        Am J Ophthalmol. 2018; 187: 148-152
        • Bonomi L
        • Marchini G
        • Marraffa M
        • et al.
        Vascular risk factors for primary open angle glaucoma: The Egna-Neumarkt study.
        Ophthalmology. 2000; 107: 1287-1293
        • Dielemans I
        • Vingerling JR
        • Algra D
        • et al.
        Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: The Rotterdam study.
        Ophthalmology. 1995; 102: 54-60
        • Jonas JB
        • Martus P
        • Budde WM
        Anisometropia and degree of optic nerve damage in chronic open-angle glaucoma.
        Am J Ophthalmol. 2002; 134: 547-551
        • Leske MC
        • Wu SY
        • Nemesure B
        • Hennis A
        Incident open-angle glaucoma and blood pressure.
        Arch Ophthalmol. 2002; 120: 954-959
        • Mitchell P
        • Lee AJ
        • Rochtchina E
        • Wang JJ
        Open-angle glaucoma and systemic hypertension: The Blue Mountains eye study.
        J Glaucoma. 2004; 13: 319-326
        • Swaminathan SS
        • Bhakta AS
        • Shi W
        • et al.
        Is obstructive sleep apnea associated with progressive glaucomatous optic neuropathy?.
        J Glaucoma. 2018; 27: 1-6
        • Weih LM
        • Nanjan M
        • McCarty CA
        • Taylor HR
        Prevalence and predictors of open-angle glaucoma: Results from the visual impairment project.
        Ophthalmology. 2001; 108: 1966-1972
        • Collaborative Normal-Tension Glaucoma Study Group
        Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures.
        Am J Ophthalmol. 1998; 126: 487-497
        • Collaborative Normal-Tension Glaucoma Study Group
        The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma.
        Am J Ophthalmol. 1998; 126: 498-505
        • Leske MC
        • Heijl A
        • Hussein M
        • et al.
        Early manifest glaucoma trial group. Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial.
        Arch Ophthalmol. 2003; 121: 48-56
        • Heijl A
        • Leske MC
        • Bengtsson B
        • et al.
        Early manifest glaucoma trial group. Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial.
        Arch Ophthalmol. 2002; 120: 1268-1279
        • AGIS investigators
        The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.
        Am J Ophthalmol. 2000; 130: 429-440
        • Garway-Heath DF
        • Crabb DP
        • Bunce C
        • et al.
        Latanoprost for open-angle glaucoma (UKGTS): A randomised, multicentre, placebo-controlled trial.
        Lancet. 2015; 385: 1295-1304
        • Bonomi L
        • Marchini G
        • Marraffa M
        • et al.
        Prevalence of glaucoma and intraocular pressure distribution in a defined population: The Egna-Neumarkt study.
        Ophthalmology. 1998; 105: 209-215
        • Jay JL
        • Murray SB
        Early trabeculectomy versus conventional management in primary open angle glaucoma.
        Br J Ophthalmol. 1988; 72: 881-889
        • Jay JL
        • Allan D
        The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease.
        Eye. 1989; 3: 528-535
        • Migdal C
        • Gregory W
        • Hitchings R
        Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma.
        Ophthalmology. 1994; 101 (discussion 1657.): 1651-1656
        • Leske MC
        • Heijl A
        • Hyman L
        • et al.
        Early manifest glaucoma trial group. Predictors of long-term progression in the early manifest glaucoma trial.
        Ophthalmology. 2007; 114: 1965-1972
        • Lichter PR
        • Musch DC
        • Gillespie BW
        • et al.
        Cigts study group. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery.
        Ophthalmology. 2001; 108: 1943-1953
        • AGIS investigators
        The advanced glaucoma intervention study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results.
        Ophthalmology. 2004; 111: 651-664
        • Friedman DS
        • Jampel HD
        • Munoz B
        • West SK
        The prevalence of open-angle glaucoma among Blacks and Whites 73 years and older: The Salisbury eye evaluation glaucoma study.
        Arch Ophthalmol. 2006; 124: 1625-1630
        • De Moraes CG
        • Juthani VJ
        • Liebmann JM
        • et al.
        Risk factors for visual field progression in treated glaucoma.
        Arch Ophthalmol. 2011; 129: 562-568
        • De Moraes CG
        • Liebmann JM
        • Greenfield DS
        • et al.
        Low-pressure glaucoma treatment study group. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
        Am J Ophthalmol. 2012; 154: 702-711
        • Caprioli J
        • Coleman AL
        Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
        Ophthalmology. 2008; 115: 1123-1129
        • Wolfs RC
        • Klaver CC
        • Ramrattan RS
        • et al.
        Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study.
        Arch Ophthalmol. 1998; 116: 1640-1645
        • Doshi V
        • Ying-Lai M
        • Azen SP
        • Varma R
        Los Angeles Latino eye study group. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. The Los Angeles Latino eye study.
        Ophthalmology. 2008; 115: 639-647
        • Tielsch JM
        • Katz J
        • Sommer A
        • et al.
        Family history and risk of primary open angle glaucoma. The Baltimore eye survey.
        Arch Ophthalmol. 1994; 112: 69-73
        • Rotchford AP
        • Johnson GJ
        Glaucoma in zulus: A population-based cross-sectional survey in a rural district in South Africa.
        Arch Ophthalmol. 2002; 120: 471-478
        • Rotchford AP
        • Kirwan JF
        • Muller MA
        • et al.
        Temba glaucoma study: A population-based cross-sectional survey in urban South Africa.
        Ophthalmology. 2003; 110: 376-382
        • Stone EM
        • Fingert JH
        • Alward WL
        • et al.
        Identification of a gene that causes primary open angle glaucoma.
        Science. 1997; 275: 668-670
        • Rezaie T
        • Child A
        • Hitchings R
        • et al.
        Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
        Science. 2002; 295: 1077-1079
        • Pasutto F
        • Keller KE
        • Weisschuh N
        • et al.
        Variants in ASB10 are associated with open-angle glaucoma.
        Hum Mol Genet. 2012; 21: 1336-1349
        • Burdon KP
        • Macgregor S
        • Hewitt AW
        • et al.
        Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1.
        Nat Genet. 2011; 43: 574-578
        • Hysi PG
        • Cheng CY
        • Springelkamp H
        • et al.
        Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma.
        Nat Genet. 2014; 46: 1126-1130
        • Ozel AB
        • Moroi SE
        • Reed DM
        • et al.
        Genome-wide association study and meta-analysis of intraocular pressure.
        Hum Genet. 2014; 133: 41-57
        • van Koolwijk LM
        • Ramdas WD
        • Ikram MK
        • et al.
        Common genetic determinants of intraocular pressure and primary open-angle glaucoma.
        PLoS Genet. 2012; 8e1002611
        • Gao X
        • Gauderman WJ
        • Liu Y
        • et al.
        A genome-wide association study of central corneal thickness in Latinos.
        Invest Ophthalmol Vis Sci. 2013; 54: 2435-2443
        • Lu Y
        • Vitart V
        • Burdon KP
        • et al.
        Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus.
        Nat Genet. 2013; 45: 155-163
        • Ulmer M
        • Li J
        • Yaspan BL
        • et al.
        Genome-wide analysis of central corneal thickness in primary open-angle glaucoma cases in the neighbor and glaugen consortia.
        Invest Ophthalmol Vis Sci. 2012; 53: 4468-4474
        • Springelkamp H
        • Hohn R
        • Mishra A
        • et al.
        Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous process.
        Nat Commun. 2014; 54883
        • Wiggs JL
        • Yaspan BL
        • Hauser MA
        • et al.
        Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.
        PLoS Genet. 2012; 8e1002654
        • Carnes MU
        • Liu YP
        • Allingham RR
        • et al.
        Discovery and functional annotation of six6 variants in primary open-angle glaucoma.
        PLoS Genet. 2014; 10e1004372
        • Loomis SJ
        • Kang JH
        • Weinreb RN
        • et al.
        Association of CAV1/CAV2 genomic variants with primary open-angle glaucoma overall and by gender and pattern of visual field loss.
        Ophthalmology. 2014; 121: 508-516
        • Chen M
        • Yu X
        • Xu J
        • et al.
        Association of gene polymorphisms with primary open angle glaucoma: A systematic review and meta-analysis.
        Invest Ophthalmol Vis Sci. 2019; 60: 1105-1121
        • Wiggs JL
        • Pasquale LR
        Genetics of glaucoma.
        Hum Mol Genet. 2017; 26: R21-R27
        • Stamenkovic M
        • Lukic V
        • Suvakov S
        • et al.
        GSTM1-null and GSTT1-active genotypes as risk determinants of primary open angle glaucoma among smokers.
        Int J Ophthalmol. 2018; 11: 1514-1520
        • Consugar MB
        • Navarro-Gomez D
        • Place EM
        • et al.
        Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing.
        Genet Med. 2015; 17: 253-261
        • American Academy of Ophthalmology
        Policy statement. Recommendations for genetic testing of inherited eye diseases.
        American Academy of Ophthalmology, San Francisco, CA2014
        • Shah S
        • Chatterjee A
        • Mathai M
        • et al.
        Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic.
        Ophthalmology. 1999; 106: 2154-2160
        • Whitacre MM
        • Stein RA
        • Hassanein K
        The effect of corneal thickness on applanation tonometry.
        Am J Ophthalmol. 1993; 115: 592-596
        • Goldmann H
        • Schmidt T
        Applanation tonometry [in German].
        Ophthalmologica. 1957; 134: 221-242
        • Ehlers N
        • Bramsen T
        • Sperling S
        Applanation tonometry and central corneal thickness.
        Acta Ophthalmol (Copenh). 1975; 53: 34-43
        • Stodtmeister R
        Applanation tonometry and correction according to corneal thickness.
        Acta Ophthalmol Scand. 1998; 76: 319-324
        • Doughty MJ
        • Zaman ML
        Human corneal thickness and its impact on intraocular pressure measures: A review and meta-analysis approach.
        Surv Ophthalmol. 2000; 44: 367-408
        • Medeiros FA
        • Sample PA
        • Zangwill LM
        • et al.
        Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy.
        Am J Ophthalmol. 2003; 136: 805-813
        • Aghaian E
        • Choe JE
        • Lin S
        • Stamper RL
        Central corneal thickness of Caucasians, Chinese, Hispanics, Filipinos, African Americans, and Japanese in a glaucoma clinic.
        Ophthalmology. 2004; 111: 2211-2219
        • Hahn S
        • Azen S
        • Ying-Lai M
        • Varma R
        Los Angeles Latino eye study group. Central corneal thickness in Latinos.
        Invest Ophthalmol Vis Sci. 2003; 44: 1508-1512
        • Chua J
        • Tham YC
        • Liao J
        • et al.
        Ethnic differences of intraocular pressure and central corneal thickness: The Singapore epidemiology of eye diseases study.
        Ophthalmology. 2014; 121: 2013-2022
        • Torres RJ
        • Jones E
        • Edmunds B
        • et al.
        Central corneal thickness in Northwestern American Indians/Alaskan Natives and comparison with White and African-American persons.
        Am J Ophthalmol. 2008; 146: 747-751
        • Shimmyo M
        • Ross AJ
        • Moy A
        • Mostafavi R
        Intraocular pressure, goldmann applanation tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispanics, and African Americans.
        Am J Ophthalmol. 2003; 136: 603-613
        • Orssengo GJ
        • Pye DC
        Determination of the true intraocular pressure and modulus of elasticity of the human cornea in vivo.
        Bull Math Biol. 1999; 61: 551-572
      1. Weinreb RN Brandt JD Garway-Heath D Medeiros FA Intraocular pressure: Reports and consensus statements of the 4th global AIGS consensus meeting on intraocular pressure. Kugler Publications, The Netherlands2007
        • Brandt JD
        • Gordon MO
        • Gao F
        • et al.
        Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.
        Ophthalmology. 2012; 119: 437-442
        • Dueker DK
        • Singh K
        • Lin SC
        • et al.
        Corneal thickness measurement in the management of primary open-angle glaucoma: A report by the American Academy of Ophthalmology.
        Ophthalmology. 2007; 114: 1779-1787
        • Francis BA
        • Varma R
        • Chopra V
        • et al.
        Intraocular pressure, central corneal thickness, and prevalence of open-angle glaucoma: The Los Angeles Latino eye study.
        Am J Ophthalmol. 2008; 146: 741-746
        • Liu J
        • Roberts CJ
        Influence of corneal biomechanical properties on intraocular pressure measurement: Quantitative analysis.
        J Cataract Refract Surg. 2005; 31: 146-155
        • Congdon NG
        • Broman AT
        • Bandeen-Roche K
        • et al.
        Central corneal thickness and corneal hysteresis associated with glaucoma damage.
        Am J Ophthalmol. 2006; 141: 868-875
        • Medeiros FA
        • Meira-Freitas D
        • Lisboa R
        • et al.
        Corneal hysteresis as a risk factor for glaucoma progression: A prospective longitudinal study.
        Ophthalmology. 2013; 120: 1533-1540
        • De Moraes CV
        • Hill V
        • Tello C
        • et al.
        Lower corneal hysteresis is associated with more rapid glaucomatous visual field progression.
        J Glaucoma. 2012; 21: 209-213
        • Shin J
        • Kim TW
        • Park SJ
        • et al.
        Changes in biomechanical properties of the cornea and intraocular pressure after myopic laser in situ keratomileusis using a femtosecond laser for flap creation determined using ocular response analyzer and goldmann applanation tonometry.
        J Glaucoma. 2015; 24: 195-201
        • Pepose JS
        • Feigenbaum SK
        • Qazi MA
        • et al.
        Changes in corneal biomechanics and intraocular pressure following lasik using static, dynamic, and noncontact tonometry.
        Am J Ophthalmol. 2007; 143: 39-47
        • Kirwan C
        • O'Keefe M
        Measurement of intraocular pressure in lasik and lasek patients using the Reichert ocular response analyzer and Goldmann applanation tonometry.
        J Refract Surg. 2008; 24: 366-370
        • Qazi MA
        • Sanderson JP
        • Mahmoud AM
        • et al.
        Postoperative changes in intraocular pressure and corneal biomechanical metrics laser in situ keratomileusis versus laser-assisted subepithelial keratectomy.
        J Cataract Refract Surg. 2009; 35: 1774-1788
        • Memarzadeh F
        • Ying-Lai M
        • Chung J
        • et al.
        Los Angeles Latino eye study group. Blood pressure, perfusion pressure, and open-angle glaucoma: The Los Angeles Latino eye study.
        Invest Ophthalmol Vis Sci. 2010; 51: 2872-2877
        • Charlson ME
        • de Moraes CG
        • Link A
        • et al.
        Nocturnal systemic hypotension increases the risk of glaucoma progression.
        Ophthalmology. 2014; 121: 2004-2012
        • Topouzis F
        • Wilson MR
        • Harris A
        • et al.
        Association of open-angle glaucoma with perfusion pressure status in the Thessaloniki eye study.
        Am J Ophthalmol. 2013; 155: 843-851
        • Khawaja AP
        • Crabb DP
        • Jansonius NM
        The role of ocular perfusion pressure in glaucoma cannot be studied with multivariable regression analysis applied to surrogates.
        Invest Ophthalmol Vis Sci. 2013; 54: 4619-4620
        • Dielemans I
        • de Jong PT
        • Stolk R
        • et al.
        Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam study.
        Ophthalmology. 1996; 103: 1271-1275
        • Pasquale LR
        • Kang JH
        • Manson JE
        • et al.
        Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women.
        Ophthalmology. 2006; 113: 1081-1086
        • de Voogd S
        • Ikram MK
        • Wolfs RC
        • et al.
        Is diabetes mellitus a risk factor for open-angle glaucoma?: The Rotterdam study.
        Ophthalmology. 2006; 113: 1827-1831
        • Klein BE
        • Klein R
        • Jensen SC
        Open-angle glaucoma and older-onset diabetes: The Beaver Dam eye study.
        Ophthalmology. 1994; 101: 1173-1177
        • Nakamura M
        • Kanamori A
        • Negi A
        Diabetes mellitus as a risk factor for glaucomatous optic neuropathy.
        Ophthalmologica. 2005; 219: 1-10
        • Vijaya L
        • George R
        • Paul PG
        • et al.
        Prevalence of open-angle glaucoma in a rural South Indian population.
        Invest Ophthalmol Vis Sci. 2005; 46: 4461-4467
        • Luo XY
        • Tan NYQ
        • Chee ML
        • et al.
        Direct and indirect associations between diabetes and intraocular pressure: The Singapore epidemiology of eye diseases study.
        Invest Ophthalmol Vis Sci. 2018; 59: 2205-2211
        • Wong TY
        • Klein BE
        • Klein R
        • et al.
        Refractive errors, intraocular pressure, and glaucoma in a White population.
        Ophthalmology. 2003; 110: 211-217
        • Ramakrishnan R
        • Nirmalan PK
        • Krishnadas R
        • et al.
        Glaucoma in a rural population of Southern India: The Aravind comprehensive eye survey.
        Ophthalmology. 2003; 110: 1484-1490
        • Suzuki Y
        • Iwase A
        • Araie M
        • et al.
        Risk factors for open-angle glaucoma in a Japanese population: The Tajimi study.
        Ophthalmology. 2006; 113: 1613-1617
        • Wu SY
        • Nemesure B
        • Leske MC
        Glaucoma and myopia.
        Ophthalmology. 2000; 107: 1026-1027
        • Krupin T
        • Liebmann JM
        • Greenfield DS
        • et al.
        Low-pressure glaucoma study group. The low-pressure glaucoma treatment study (LOGTS) study design and baseline characteristics of enrolled patients.
        Ophthalmology. 2005; 112: 376-385
        • Drance S
        • Anderson DR
        • Schulzer M
        Risk factors for progression of visual field abnormalities in normal-tension glaucoma.
        Am J Ophthalmol. 2001; 131: 699-708
        • Huang JY
        • Su CC
        • Wang TH
        • Tsai IJ
        Migraine and increased risk of developing open angle glaucoma: A population-based cohort study.
        BMC Ophthalmol. 2019; 19: 50
        • Park HY
        • Park SH
        • Park CK
        Central visual field progression in normal-tension glaucoma patients with autonomic dysfunction.
        Invest Ophthalmol Vis Sci. 2014; 55: 2557-2563
        • Nguyen BN
        • Vingrys AJ
        • McKendrick AM
        The effect of duration post-migraine on visual electrophysiology and visual field performance in people with migraine.
        Cephalalgia. 2014; 34: 42-57
        • Bulpitt CJ
        • Hodes C
        • Everitt MG
        Intraocular pressure and systemic blood pressure in the elderly.
        Br J Ophthalmol. 1975; 59: 717-720
        • Wilson MR
        • Hertzmark E
        • Walker AM
        • et al.
        A case-control study of risk factors in open angle glaucoma.
        Arch Ophthalmol. 1987; 105: 1066-1071
        • Newman-Casey PA
        • Talwar N
        • Nan B
        • et al.
        The relationship between components of metabolic syndrome and open-angle glaucoma.
        Ophthalmology. 2011; 118: 1318-1326
        • Tan GS
        • Wong TY
        • Fong CW
        • Aung T
        Diabetes, metabolic abnormalities, and glaucoma.
        Arch Ophthalmol. 2009; 127: 1354-1361
        • Wormald RP
        • Basauri E
        • Wright LA
        • Evans JR
        The African Caribbean eye survey: Risk factors for glaucoma in a sample of African Caribbean people living in London.
        Eye (Lond). 1994; 8: 315-320
        • Kaimbo Wa Kaimbo D
        • Missotten L
        Risk factors for open-angle glaucoma in 260 black subjects in Congo.
        Bull Soc Belge Ophtalmol. 1997; 267: 29-34
        • Shiose Y
        • Kawase Y
        A new approach to stratified normal intraocular pressure in a general population.
        Am J Ophthalmol. 1986; 101: 714-721
        • Wolf S
        • Arend O
        • Sponsel WE
        • et al.
        Retinal hemodynamics using scanning laser ophthalmoscopy and hemorheology in chronic open-angle glaucoma.
        Ophthalmology. 1993; 100: 1561-1566
        • Graham SL
        • Drance SM
        Nocturnal hypotension: Role in glaucoma progression.
        Surv Ophthalmol. 1999; 43: S10-S16
        • Müskens RP
        • de Voogd S
        • Wolfs RC
        • et al.
        Systemic antihypertensive medication and incident open-angle glaucoma.
        Ophthalmology. 2007; 114: 2221-2226
        • Fleischman D
        • Allingham RR
        The role of cerebrospinal fluid pressure in glaucoma and other ophthalmic diseases: A review.
        Saudi J Ophthalmol. 2013; 27: 97-106
        • Berdahl JP
        • Allingham RR
        • Johnson DH
        Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma.
        Ophthalmology. 2008; 115: 763-768
        • Berdahl JP
        • Fautsch MP
        • Stinnett SS
        • Allingham RR
        Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: A case-control study.
        Invest Ophthalmol Vis Sci. 2008; 49: 5412-5418
        • Ren R
        • Jonas JB
        • Tian G
        • et al.
        Cerebrospinal fluid pressure in glaucoma: A prospective study.
        Ophthalmology. 2010; 117: 259-266
        • Ren R
        • Zhang X
        • Wang N
        • et al.
        Cerebrospinal fluid pressure in ocular hypertension.
        Acta Ophthalmol. 2011; 89: e142-e148
        • Abegão Pinto L
        • Vandewalle E
        • Pronk A
        • Stalmans I
        Intraocular pressure correlates with optic nerve sheath diameter in patients with normal tension glaucoma.
        Graefes Arch Clin Exp Ophthalmol. 2012; 250: 1075-1080
        • Lin HC
        • Kang JH
        • Jiang YD
        • Ho JD
        Hypothyroidism and the risk of developing open-angle glaucoma: A five-year population-based follow-up study.
        Ophthalmology. 2010; 117: 1960-1966
        • Thvilum M
        • Brandt F
        • Brix TH
        • Hegedus L
        The interrelation between hypothyroidism and glaucoma: A critical review and meta-analyses.
        Acta Ophthalmol. 2017; 95: 759-767
        • Coleman AL
        • Mansberger SL
        • Wilson MR
        Epidemiology of primary open-angle glaucoma.
        in: Albert DM Miller JW Azar DT Blodi BA Albert & Jakobiec's principles & practice of ophthalmology. 3rd ed. Saunders/Elsevier, Philadelphia, PA2008 (Chapter 36.)
        • Freeman EE
        • Munoz B
        • West SK
        • et al.
        Glaucoma and quality of life: The Salisbury eye evaluation.
        Ophthalmology. 2008; 115: 233-238
        • McKean-Cowdin R
        • Wang Y
        • Wu J
        • et al.
        Los Angeles Latino eye study group. Impact of visual field loss on health-related quality of life in glaucoma: The Los Angeles Latino eye study.
        Ophthalmology. 2008; 115: 941-948
        • Burr JM
        • Mowatt G
        • Hernandez R
        • et al.
        The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: A systematic review and economic evaluation.
        Health Technol Assess. 2007; 11 (ix-x, 1-190.): iii-iiv
        • Hernandez RA
        • Burr JM
        • Vale LD
        Economic evaluation of screening for open-angle glaucoma.
        Int J Technol Assess Health Care. 2008; 24: 203-211
        • Klein BE
        • Klein R
        • Lee KE
        Heritability of risk factors for primary open-angle glaucoma: The Beaver Dam eye study.
        Invest Ophthalmol Vis Sci. 2004; 45: 59-62
        • Duggal P
        • Klein AP
        • Lee KE
        • et al.
        A genetic contribution to intraocular pressure: The Beaver Dam eye study.
        Invest Ophthalmol Vis Sci. 2005; 46: 555-560
        • Mitchell P
        • Rochtchina E
        • Lee AJ
        • Wang JJ
        Bias in self-reported family history and relationship to glaucoma: The Blue Mountains eye study.
        Ophthalmic Epidemiol. 2002; 9: 333-345
        • Tielsch JM
        • Katz J
        • Singh K
        • et al.
        A population-based evaluation of glaucoma screening: The Baltimore eye survey.
        Am J Epidemiol. 1991; 134: 1102-1110
        • Hollows FC
        • Graham P
        Intraocular pressure, glaucoma and glaucoma suspects in a defined population.
        Br J Ophthalmol. 1966; 50: 570-586
        • Sommer A
        Disabling visual disorders. Public health and preventive medicine.
        12th ed. Appleton-Century-Crofts, Norwalk1986
        • Lichter PR
        Variability of expert observers in evaluating the optic disc.
        Trans Am Ophthalmol Soc. 1976; 74: 532-572
        • Kahn HA
        • Leibowitz HM
        • Ganley JP
        Standardizing diagnostic procedures.
        Am J Ophthalmol. 1975; 79: 768-775
        • Springelkamp H
        • Lee K
        • Wolfs RC
        • et al.
        Population-based evaluation of retinal nerve fiber layer, retinal ganglion cell layer, and inner plexiform layer as a diagnostic tool for glaucoma.
        Invest Ophthalmol Vis Sci. 2014; 55: 8428-8438
        • Francis BA
        • Varma R
        • Vigen C
        • et al.
        Population and high-risk group screening for glaucoma: The Los Angeles Latino eye study.
        Invest Ophthalmol Vis Sci. 2011; 52: 6257-6264
        • Li G
        • Fansi AK
        • Harasymowycz P
        Screening for glaucoma using GDx-VCC in a population with >/=1 risk factors.
        Can J Ophthalmol. 2013; 48: 279-285
        • Anderson DR
        • Patella VM
        Automated static perimetry.
        2nd ed. Mosby, St. Louis, MO1999: 10-31 (121-188, 281-282, 317-320.)
        • Quigley HA
        Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology.
        Am J Ophthalmol. 1998; 125: 819-829
        • Tatemichi M
        • Nakano T
        • Tanaka K
        • et al.
        Glaucoma screening project (GSP) study group. Performance of glaucoma mass screening with only a visual field test using frequency-doubling technology perimetry.
        Am J Ophthalmol. 2002; 134: 529-537
        • Hark LA
        • Adeghate J
        • Katz LJ
        • et al.
        Philadelphia telemedicine glaucoma detection and follow-up study: Cataract classifications following eye screening.
        Telemed J E Health. 2020; 26: 992-1000
        • Maa AY
        • Medert CM
        • Lu X
        • et al.
        Diagnostic accuracy of technology-based eye care services: The technology-based eye care services compare trial part i.
        Ophthalmology. 2020; 127: 38-44
        • Ting DSW
        • Pasquale LR
        • Peng L
        • et al.
        Artificial intelligence and deep learning in ophthalmology.
        Br J Ophthalmol. 2019; 103: 167-175
        • Liu S
        • Graham SL
        • Schulz A
        • et al.
        A deep learning-based algorithm identifies glaucomatous discs using monoscopic fundus photographs.
        Ophthalmology Glaucoma. 2018; 1: 15-22
        • Shigueoka LS
        • Vasconcellos JPC
        • Schimiti RB
        • et al.
        Automated algorithms combining structure and function outperform general ophthalmologists in diagnosing glaucoma.
        PLoS One. 2018; 13e0207784
      2. Centers for Medicare and Medicaid Services. Your medicare coverage: Glaucoma tests.

        • American Academy of Ophthalmology Preferred Practice Patterns Committee
        Preferred Practice Pattern® Guidelines. Comprehensive adult medical eye evaluation.
        American Academy of Ophthalmology, San Francisco, CA2015
        • Mansberger SL
        • Gordon MO
        • Jampel H
        • et al.
        Reduction in intraocular pressure after cataract extraction: The ocular hypertension treatment study.
        Ophthalmology. 2012; 119: 1826-1831
        • Friedman DS
        • Jampel HD
        • Lubomski LH
        • et al.
        Surgical strategies for coexisting glaucoma and cataract: An evidence-based update.
        Ophthalmology. 2002; 109: 1902-1913
        • Svedberg H
        • Chen E
        • Hamberg-Nystrom H
        Changes in corneal thickness and curvature after different excimer laser photorefractive procedures and their impact on intraocular pressure measurements.
        Graefes Arch Clin Exp Ophthalmol. 2005; 243: 1218-1220
        • Montes-Mico R
        • Charman WN
        Intraocular pressure after excimer laser myopic refractive surgery.
        Ophthalmic Physiol Opt. 2001; 21: 228-235
        • Rashad KM
        • Bahnassy AA
        Changes in intraocular pressure after laser in situ keratomileusis.
        J Refract Surg. 2001; 17: 420-427
        • Hosny M
        • Aboalazayem F
        • El Shiwy H
        • Salem M
        Comparison of different intraocular pressure measurement techniques in normal eyes and post small incision lenticule extraction.
        Clin Ophthalmol. 2017; 11: 1309-1314
        • Gutierrez P
        • Wilson MR
        • Johnson C
        • et al.
        Influence of glaucomatous visual field loss on health-related quality of life.
        Arch Ophthalmol. 1997; 115: 777-784
        • Lee BL
        • Gutierrez P
        • Gordon M
        • et al.
        The glaucoma symptom scale: A brief index of glaucoma-specific symptoms.
        Arch Ophthalmol. 1998; 116: 861-866
        • Parrish 2nd, RK
        • Gedde SJ
        • Scott IU
        • et al.
        Visual function and quality of life among patients with glaucoma.
        Arch Ophthalmol. 1997; 115: 1447-1455
        • Wilson MR
        • Coleman AL
        • Yu F
        • et al.
        Functional status and well-being in patients with glaucoma as measured by the medical outcomes study short form-36 questionnaire.
        Ophthalmology. 1998; 105: 2112-2116
        • Aspinall PA
        • Johnson ZK
        • Azuara-Blanco A
        • et al.
        Evaluation of quality of life and priorities of patients with glaucoma.
        Invest Ophthalmol Vis Sci. 2008; 49: 1907-1915
        • Goldberg I
        • Clement CI
        • Chiang TH
        • et al.
        Assessing quality of life in patients with glaucoma using the glaucoma quality of life-15 (gql-15) questionnaire.
        J Glaucoma. 2009; 18: 6-12
        • Spaeth G
        • Walt J
        • Keener J
        Evaluation of quality of life for patients with glaucoma.
        Am J Ophthalmol. 2006; 141: S3-14
        • Bechetoille A
        • Arnould B
        • Bron A
        • et al.
        Measurement of health-related quality of life with glaucoma: Validation of the Glau-QoL 36-item questionnaire.
        Acta Ophthalmol. 2008; 86: 71-80
        • McKean-Cowdin R
        • Varma R
        • Wu J
        • et al.
        Los Angeles Latino eye study group. Severity of visual field loss and health-related quality of life.
        Am J Ophthalmol. 2007; 143: 1013-1023
        • Ringsdorf L
        • McGwin Jr., G
        • Owsley C
        Visual field defects and vision-specific health-related quality of life in African Americans and Whites with glaucoma.
        J Glaucoma. 2006; 15: 414-418
        • Varma R
        • Wu J
        • Chong K
        • et al.
        Los Angeles Latino eye study group. Impact of severity and bilaterality of visual impairment on health-related quality of life.
        Ophthalmology. 2006; 113: 1846-1853
        • Lisboa R
        • Chun YS
        • Zangwill LM
        • et al.
        Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma.
        JAMA Ophthalmol. 2013; 131: 486-494
        • Crabb DP
        • Smith ND
        • Glen FC
        • et al.
        How does glaucoma look?: Patient perception of visual field loss.
        Ophthalmology. 2013; 120: 1120-1126
        • Ramulu PY
        • West SK
        • Munoz B
        • et al.
        Glaucoma and reading speed: The Salisbury eye evaluation project.
        Arch Ophthalmol. 2009; 127: 82-87
        • Gracitelli CP
        • Abe RY
        • Tatham AJ
        • et al.
        Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma.
        JAMA Ophthalmol. 2015; 133: 384-390
        • Aasved H
        Relationship of intraocular pressure and fibrillopathia epitheliocapsularis.
        Trans Ophthalmol Soc U K. 1979; 99: 310-311
        • Kohn AN
        • Moss AP
        • Podos SM
        Relative afferent pupillary defects in glaucoma without characteristic field loss.
        Arch Ophthalmol. 1979; 97: 294-296
        • Brown RH
        • Zilis JD
        • Lynch MG
        • Sanborn GE
        The afferent pupillary defect in asymmetric glaucoma.
        Arch Ophthalmol. 1987; 105: 1540-1543
        • Kerrison JB
        • Buchanan K
        • Rosenberg ML
        • et al.
        Quantification of optic nerve axon loss associated with a relative afferent pupillary defect in the monkey.
        Arch Ophthalmol. 2001; 119: 1333-1341
        • Chang DS
        • Xu L
        • Boland MV
        • Friedman DS
        Accuracy of pupil assessment for the detection of glaucoma: A systematic review and meta-analysis.
        Ophthalmology. 2013; 120: 2217-2225
        • Foster PJ
        • Devereux JG
        • Alsbirk PH
        • et al.
        Detection of gonioscopically occludable angles and primary angle closure glaucoma by estimation of limbal chamber depth in Asians: Modified grading scheme.
        Br J Ophthalmol. 2000; 84: 186-192
        • Van Herick W
        • Shaffer RN
        • Schwartz A
        Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle.
        Am J Ophthalmol. 1969; 68: 626-629
        • Barkana Y
        • Anis S
        • Liebmann J
        • et al.
        Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma.
        Arch Ophthalmol. 2006; 124: 793-797
        • Hasegawa K
        • Ishida K
        • Sawada A
        • et al.
        Diurnal variation of intraocular pressure in suspected normal-tension glaucoma.
        Jpn J Ophthalmol. 2006; 50: 449-454
        • Dinn RB
        • Zimmerman MB
        • Shuba LM
        • et al.
        Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma.
        Ophthalmology. 2007; 114: 915-920
        • Bagga H
        • Liu JH
        • Weinreb RN
        Intraocular pressure measurements throughout the 24 h.
        Curr Opin Ophthalmol. 2009; 20: 79-83
        • Nouri-Mahdavi K
        • Hoffman D
        • Coleman AL
        • et al.
        Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study.
        Ophthalmology. 2004; 111: 1627-1635
        • Musch DC
        • Gillespie BW
        • Lichter PR
        • et al.
        CIGTS study investigators. Visual field progression in the collaborative initial glaucoma treatment study the impact of treatment and other baseline factors.
        Ophthalmology. 2009; 116: 200-207
        • Nouri-Mahdavi K
        • Medeiros FA
        • Weinreb RN
        Fluctuation of intraocular pressure as a predictor of visual field progression.
        Arch Ophthalmol. 2008; 126 (author reply 1169-1170.): 1168-1169
        • Asrani S
        • Zeimer R
        • Wilensky J
        • et al.
        Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma.
        J Glaucoma. 2000; 9: 134-142
        • Zhang ML
        • Chon BH
        • Wang J
        • et al.
        Single vs multiple intraocular pressure measurements in glaucoma surgical trials.
        JAMA Ophthalmol. 2014; 132: 956-962
        • Konstas AG
        • Kahook MY
        • Araie M
        • et al.
        Diurnal and 24-h intraocular pressures in glaucoma: Monitoring strategies and impact on prognosis and treatment.
        Adv Ther. 2018; 35: 1775-1804
      3. Tasman W Jaeger EA Duane's ophthalmology. 15th ed. Lippincott Williams & Wilkins, Philadelphia, PA2009
        • Spaeth GL
        • Aruajo S
        • Azuara A
        Comparison of the configuration of the human anterior chamber angle, as determined by the spaeth gonioscopic grading system and ultrasound biomicroscopy.
        Trans Am Ophthalmol Soc. 1995; 93 (discussion 347-351.): 337-347
        • Quigley HA
        • Enger C
        • Katz J
        • et al.
        Risk factors for the development of glaucomatous visual field loss in ocular hypertension.
        Arch Ophthalmol. 1994; 112: 644-649
        • Sommer A
        • Katz J
        • Quigley HA
        • et al.
        Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss.
        Arch Ophthalmol. 1991; 109: 77-83
        • Lin SC
        • Singh K
        • Jampel HD
        • et al.
        Optic nerve head and retinal nerve fiber layer analysis: A report by the American Academy of Ophthalmology.
        Ophthalmology. 2007; 114: 1937-1949
        • Lloyd MJ
        • Mansberger SL
        • Fortune BA
        • et al.
        Features of optic disc progression in patients with ocular hypertension and early glaucoma.
        J Glaucoma. 2013; 22: 343-348
        • Harizman N
        • Oliveira C
        • Chiang A
        • et al.
        The ISNT rule and differentiation of normal from glaucomatous eyes.
        Arch Ophthalmol. 2006; 124: 1579-1583
        • Hwang YH
        • Kim YY
        Application of the ISNT rule to neuroretinal rim thickness determined using cirrus HD optical coherence tomography.
        J Glaucoma. 2015; 24: 503-507
        • Poon LY
        • Sola-Del Valle D
        • Turalba AV
        • et al.
        The ISNT rule: How often does it apply to disc photographs and retinal nerve fiber layer measurements in the normal population?.
        Am J Ophthalmol. 2017; 184: 19-27
        • Johnson CA
        • Cioffi GA
        • Liebmann JR
        • et al.
        The relationship between structural and functional alterations in glaucoma: A review.
        Semin Ophthalmol. 2000; 15: 221-233
        • Medeiros FA
        • Alencar LM
        • Zangwill LM
        • et al.
        Prediction of functional loss in glaucoma from progressive optic disc damage.
        Arch Ophthalmol. 2009; 127: 1250-1256
        • Teng CC
        • De Moraes CG
        • Prata TS
        • et al.
        The region of largest beta-zone parapapillary atrophy area predicts the location of most rapid visual field progression.
        Ophthalmology. 2011; 118: 2409-2413
        • Harwerth RS
        • Vilupuru AS
        • Rangaswamy NV
        • Smith III, EL
        The relationship between nerve fiber layer and perimetry measurements.
        Invest Ophthalmol Vis Sci. 2007; 48: 763-773
        • Hood DC
        • Kardon RH
        A framework for comparing structural and functional measures of glaucomatous damage.
        Prog Retin Eye Res. 2007; 26: 688-710
        • Miglior S
        • Torri V
        • Zeyen T
        • et al.
        Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
        Am J Ophthalmol. 2007; 144: 266-275
        • De Moraes CG
        • Prata TS
        • Liebmann CA
        • et al.
        Spatially consistent, localized visual field loss before and after disc hemorrhage.
        Invest Ophthalmol Vis Sci. 2009; 50: 4727-4733
        • Jeoung JW
        • Park KH
        • Kim JM
        • et al.
        Optic disc hemorrhage may be associated with retinal nerve fiber loss in otherwise normal eyes.
        Ophthalmology. 2008; 115: 2132-2140
        • Hwang YH
        • Kim YY
        • Kim HK
        • Sohn YH
        Changes in retinal nerve fiber layer thickness after optic disc hemorrhage in glaucomatous eyes.
        J Glaucoma. 2014; 23: 547-552
        • Bengtsson B
        • Leske MC
        • Yang Z
        • Heijl A
        Early manifest glaucoma trial group. Disc hemorrhages and treatment in the early manifest glaucoma trial.
        Ophthalmology. 2008; 115: 2044-2048
        • de Beaufort HC
        • De Moraes CG
        • Teng CC
        • et al.
        Recurrent disc hemorrhage does not increase the rate of visual field progression.
        Graefes Arch Clin Exp Ophthalmol. 2010; 248: 839-844
        • Laemmer R
        • Nguyen TK
        • Horn FK
        • Mardin CY
        Morphologic and functional glaucomatous change after occurrence of single or recurrent optic disc hemorrhages.
        Graefes Arch Clin Exp Ophthalmol. 2010; 248 (author reply 1685.): 1683-1684
        • Singh K
        • Lee BL
        • Wilson MR
        Glaucoma modified rand-like methodology group. A panel assessment of glaucoma management: Modification of existing rand-like methodology for consensus in ophthalmology. Part ii: Results and interpretation.
        Am J Ophthalmol. 2008; 145: 575-581
        • Quigley HA
        • Sommer A
        How to use nerve fiber layer examination in the management of glaucoma.
        Trans Am Ophthalmol Soc. 1987; 85: 254-272
        • Agudelo LM
        • Molina CA
        • Alvarez DL
        Changes in intraocular pressure after laser in situ keratomileusis for myopia, hyperopia, and astigmatism.
        J Refract Surg. 2002; 18: 472-474
        • Miglior S
        • Pfeiffer N
        • Torri V
        • et al.
        Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European glaucoma prevention study.
        Ophthalmology. 2007; 114: 3-9
        • Kim JW
        • Chen PP
        Central corneal pachymetry and visual field progression in patients with open-angle glaucoma.
        Ophthalmology. 2004; 111: 2126-2132
        • Chauhan BC
        • Hutchison DM
        • LeBlanc RP
        • et al.
        Central corneal thickness and progression of the visual field and optic disc in glaucoma.
        Br J Ophthalmol. 2005; 89: 1008-1012
        • Jonas JB
        • Stroux A
        • Oberacher-Velten IM
        • et al.
        Central corneal thickness and development of glaucomatous optic disk hemorrhages.
        Am J Ophthalmol. 2005; 140: 1139-1141
        • Jonas JB
        • Stroux A
        • Velten I
        • et al.
        Central corneal thickness correlated with glaucoma damage and rate of progression.
        Invest Ophthalmol Vis Sci. 2005; 46: 1269-1274
        • Stewart WC
        • Day DG
        • Jenkins JN
        • et al.
        Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma.
        J Ocul Pharmacol Ther. 2006; 22: 26-33
        • Wurster P
        • Harris A
        • Gonzalez AC
        • et al.
        Risk factors for open-angle glaucoma in persons of Latin American descent.
        J Glaucoma. 2020; 29: 217-225
        • Zhang B
        • Shweikh Y
        • Khawaja AP
        • et al.
        Associations with corneal hysteresis in a population cohort: Results from 96 010 UK biobank participants.
        Ophthalmology. 2019; 126: 1500-1510
        • Jampel HD
        • Singh K
        • Lin SC
        • et al.
        Assessment of visual function in glaucoma: A report by the American Academy of Ophthalmology.
        Ophthalmology. 2011; 118: 986-1002
        • De Moraes CG
        • Hood DC
        • Thenappan A
        • et al.
        24-2 visual fields miss central defects shown on 10-2 tests in glaucoma suspects, ocular hypertensives, and early glaucoma.
        Ophthalmology. 2017; 124: 1449-1456
        • Gordon MO
        • Kass MA
        The ocular hypertension treatment study: Design and baseline description of the participants.
        Arch Ophthalmol. 1999; 117: 573-583
        • Keltner JL
        • Johnson CA
        • Quigg JM
        • et al.
        Ocular hypertension treatment study group. Confirmation of visual field abnormalities in the ocular hypertension treatment study.
        Arch Ophthalmol. 2000; 118: 1187-1194
        • Keltner JL
        • Johnson CA
        • Levine RA
        • et al.
        Normal visual field test results following glaucomatous visual field end points in the ocular hypertension treatment study.
        Arch Ophthalmol. 2005; 123: 1201-1206
        • Delgado MF
        • Nguyen NT
        • Cox TA
        • et al.
        Automated perimetry: A report by the American Academy of Ophthalmology.
        Ophthalmology. 2002; 109: 2362-2374
        • Liu S
        • Lam S
        • Weinreb RN
        • et al.
        Comparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucoma.
        Invest Ophthalmol Vis Sci. 2011; 52: 7325-7331
        • Tafreshi A
        • Sample PA
        • Liebmann JM
        • et al.
        Visual function-specific perimetry to identify glaucomatous visual loss using three different definitions of visual field abnormality.
        Invest Ophthalmol Vis Sci. 2009; 50: 1234-1240
        • van der Schoot J
        • Reus NJ
        • Colen TP
        • Lemij HG
        The ability of short-wavelength automated perimetry to predict conversion to glaucoma.
        Ophthalmology. 2010; 117: 30-34
        • Johnson CA
        • Samuels SJ
        Screening for glaucomatous visual field loss with frequency-doubling perimetry.
        Invest Ophthalmol Vis Sci. 1997; 38: 413-425
        • Cello KE
        • Nelson-Quigg JM
        • Johnson CA
        Frequency doubling technology perimetry for detection of glaucomatous visual field loss.
        Am J Ophthalmol. 2000; 129: 314-322
        • Medeiros FA
        • Sample PA
        • Weinreb RN
        Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
        Am J Ophthalmol. 2004; 137: 863-871
        • Meira-Freitas D
        • Tatham AJ
        • Lisboa R
        • et al.
        Predicting progression of glaucoma from rates of frequency doubling technology perimetry change.
        Ophthalmology. 2014; 121: 498-507
        • Landers JA
        • Goldberg I
        • Graham SL
        Detection of early visual field loss in glaucoma using frequency-doubling perimetry and short-wavelength automated perimetry.
        Arch Ophthalmol. 2003; 121: 1705-1710
        • Demirel S
        • Johnson CA
        Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients.
        Am J Ophthalmol. 2001; 131: 709-715
        • Spaeth GL
        • Lopes JF
        • Junk AK
        • et al.
        Systems for staging the amount of optic nerve damage in glaucoma: A critical review and new material.
        Surv Ophthalmol. 2006; 51: 293-315
        • Chong GT
        • Lee RK
        Glaucoma versus red disease: Imaging and glaucoma diagnosis.
        Curr Opin Ophthalmol. 2012; 23: 79-88
        • Shaffer RN
        • Ridgway WL
        • Brown R
        • Kramer SG
        The use of diagrams to record changes in glaucomatous disks.
        Am J Ophthalmol. 1975; 80: 460-464
        • Coleman AL
        • Sommer A
        • Enger C
        • et al.
        Interobserver and intraobserver variability in the detection of glaucomatous progression of the optic disc.
        J Glaucoma. 1996; 5: 384-389
        • Iester M
        • De Ferrari R
        • Zanini M
        Topographic analysis to discriminate glaucomatous from normal optic nerve heads with a confocal scanning laser: New optic disk analysis without any observer input.
        Surv Ophthalmol. 1999; 44: S33-S40
        • Watkins RJ
        • Broadway DC
        Intraobserver and interobserver reliability indices for drawing scanning laser ophthalmoscope optic disc contour lines with and without the aid of optic disc photographs.
        J Glaucoma. 2005; 14: 351-357
        • Jampel HD
        • Friedman D
        • Quigley H
        • et al.
        Agreement among glaucoma specialists in assessing progressive disc changes from photographs in open-angle glaucoma patients.
        Am J Ophthalmol. 2009; 147: 39-44
        • Gaasterland DE
        • Blackwell B
        • Dally LG
        • et al.
        Advanced glaucoma intervention study investigators. The advanced glaucoma intervention study (AGIS): 10. Variability among academic glaucoma subspecialists in assessing optic disc notching.
        Trans Am Ophthalmol Soc. 2001; 99 (discussion 184-175.): 177-184
        • Alencar LM
        • Bowd C
        • Weinreb RN
        • et al.
        Comparison of hrt-3 glaucoma probability score and subjective stereophotograph assessment for prediction of progression in glaucoma.
        Invest Ophthalmol Vis Sci. 2008; 49: 1898-1906
        • Baraibar B
        • Sanchez-Cano A
        • Pablo LE
        • Honrubia FM
        Preperimetric glaucoma assessment with scanning laser polarimetry (GDx VCC): Analysis of retinal nerve fiber layer by sectors.
        J Glaucoma. 2007; 16: 659-664
        • Lalezary M
        • Medeiros FA
        • Weinreb RN
        • et al.
        Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects.
        Am J Ophthalmol. 2006; 142: 576-582
        • Medeiros FA
        • Zangwill LM
        • Bowd C
        • Weinreb RN
        Comparison of the GDx VCC scanning laser polarimeter, hrt ii confocal scanning laser ophthalmoscope, and stratus oct optical coherence tomograph for the detection of glaucoma.
        Arch Ophthalmol. 2004; 122: 827-837
        • Weinreb RN
        • Zangwill LM
        • Jain S
        • et al.
        OHTS CSLO ancillary study group. Predicting the onset of glaucoma: The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
        Ophthalmology. 2010; 117: 1674-1683
        • Chen TC
        • Hoguet A
        • Junk AK
        • et al.
        Spectral-domain oct: Helping the clinician diagnose glaucoma: A report by the American Academy of Ophthalmology.
        Ophthalmology. 2018; 125: 1817-1827
        • Mansberger SL
        • Menda SA
        • Fortune BA
        • et al.
        Automated segmentation errors when using optical coherence tomography to measure retinal nerve fiber layer thickness in glaucoma.
        Am J Ophthalmol. 2017; 174: 1-8
        • Meier KL
        • Greenfield DS
        • Hilmantel G
        • et al.
        Special commentary: Food and Drug Administration and American Glaucoma Society co-sponsored workshop: The validity, reliability, and usability of glaucoma imaging devices.
        Ophthalmology. 2014; 121: 2116-2123
        • Leung CK
        Diagnosing glaucoma progression with optical coherence tomography.
        Curr Opin Ophthalmol. 2014; 25: 104-111
        • Kotowski J
        • Wollstein G
        • Ishikawa H
        • Schuman JS
        Imaging of the optic nerve and retinal nerve fiber layer: An essential part of glaucoma diagnosis and monitoring.
        Surv Ophthalmol. 2014; 59: 458-467
        • Miglior S
        • Zeyen T
        • Pfeiffer N
        • et al.
        European glaucoma prevention study (EGPS) group. Results of the European glaucoma prevention study.
        Ophthalmology. 2005; 112: 366-375
        • Chauhan BC
        • McCormick TA
        • Nicolela MT
        • LeBlanc RP
        Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: Comparison of scanning laser tomography with conventional perimetry and optic disc photography.
        Arch Ophthalmol. 2001; 119: 1492-1499
        • Wollstein G
        • Schuman JS
        • Price LL
        • et al.
        Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma.
        Arch Ophthalmol. 2005; 123: 464-470
        • Higginbotham EJ
        • Gordon MO
        • Beiser JA
        • et al.
        Ocular hypertension treatment study group. The ocular hypertension treatment study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals.
        Arch Ophthalmol. 2004; 122: 813-820
        • Jay JL
        • Allan D
        The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease.
        Eye (Lond). 1989; 3: 528-535
        • Fluorouracil Filtering Surgery Study Group
        Five-year follow-up of the fluorouracil filtering surgery study.
        Am J Ophthalmol. 1996; 121: 349-366
        • Odberg T
        Visual field prognosis in advanced glaucoma.
        Acta Ophthalmol. 1987; 65: 27-29
        • Mao LK
        • Stewart WC
        • Shields MB
        Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma.
        Am J Ophthalmol. 1991; 111: 51-55
        • Kolker AE
        Visual prognosis in advanced glaucoma: A comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma.
        Trans Am Ophthalmol Soc. 1977; 75: 539-555
        • Quigley HA
        • Maumenee AE
        Long-term follow-up of treated open-angle glaucoma.
        Am J Ophthalmol. 1979; 87: 519-525
        • Greve EL
        • Dake CL
        • Klaver J
        • Mutsaerts E
        Ten year prospective follow-up of a glaucoma operation. The double flap scheie in primary open angle glaucoma.
        in: Greve EL Leydhecker W Raitta C Second European glaucoma symposium, Helsinki 1984. Dr. W Junk, Dordrecht, Netherlands1985
        • Werner EB
        • Drance SM
        • Schulzer M
        Trabeculectomy and the progression of glaucomatous visual field loss.
        Arch Ophthalmol. 1977; 95: 1374-1377
        • Kidd MN
        • O'Connor M
        Progression of field loss after trabeculectomy: A five-year follow-up.
        Br J Ophthalmol. 1985; 69: 827-831
      4. Rollins D, Drance S. Five-year follow-up of trabeculectomy in the management of chronic open-angle glaucoma. New Orleans Acad Ophthalmol, Symposium on Glaucoma 1981.

        • Chandler PA
        Long-term results in glaucoma therapy.
        Am J Ophthalmol. 1960; 49: 221-246
        • Abedin S
        • Simmons RJ
        • Grant WM
        Progressive low-tension glaucoma: Treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure.
        Ophthalmology. 1982; 89: 1-6
        • Glaucoma Laser Trial Research Group
        The glaucoma laser trial (GLT) and glaucoma laser trial follow-up study: 7. Results.
        Am J Ophthalmol. 1995; 120: 718-731
        • Fiscella RG
        • Green A
        • Patuszynski DH
        • Wilensky J
        Medical therapy cost considerations for glaucoma.
        Am J Ophthalmol. 2003; 136: 18-25
        • Nelson P
        • Aspinall P
        • Papasouliotis O
        • et al.
        Quality of life in glaucoma and its relationship with visual function.
        J Glaucoma. 2003; 12: 139-150
        • Chauhan BC
        • Garway-Heath DF
        • Goni FJ
        • et al.
        Practical recommendations for measuring rates of visual field change in glaucoma.
        Br J Ophthalmol. 2008; 92: 569-573
        • Jampel HD
        Target pressure in glaucoma therapy.
        J Glaucoma. 1997; 6: 133-138
        • Clement CI
        • Bhartiya S
        • Shaarawy T
        New perspectives on target intraocular pressure.
        Surv Ophthalmol. 2014; 59: 615-626
      5. Weinreb RN Brandt JD Garway-Heath D Medeiros FA Intraocular pressure. World Glaucoma Association consensus series - 4. Kugler Publications, The Netherlands2007
        • Whitson JT
        Glaucoma: A review of adjunctive therapy and new management strategies.
        Expert Opin Pharmacother. 2007; 8: 3237-3249
        • McKinnon SJ
        • Goldberg LD
        • Peeples P
        • et al.
        Current management of glaucoma and the need for complete therapy.
        Am J Manag Care. 2008; 14: S20-S27
        • Li T
        • Lindsley K
        • Rouse B
        • et al.
        Comparative effectiveness of first-line medications for primary open-angle glaucoma: A systematic review and network meta-analysis.
        Ophthalmology. 2016; 123: 129-140
        • Stewart WC
        • Konstas AG
        • Nelson LA
        • Kruft B
        Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
        Ophthalmology. 2008; 115: 1117-1122
        • Bhosle MJ
        • Reardon G
        • Camacho FT
        • et al.
        Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a medicare managed care population.
        Am J Geriatr Pharmacother. 2007; 5: 100-111
        • Boland MV
        • Ervin AM
        • Friedman DS
        • et al.
        Comparative effectiveness of treatments for open-angle glaucoma: A systematic review for the U.S. Preventive Services Task Force.
        Ann Intern Med. 2013; 158: 271-279
        • Weinreb RN
        • van Buskirk EM
        • Cherniack R
        • Drake MM
        Long-term betaxolol therapy in glaucoma patients with pulmonary disease.
        Am J Ophthalmol. 1988; 106: 162-167
        • Gulati V
        • Fan S
        • Zhao M
        • et al.
        Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
        Arch Ophthalmol. 2012; 130: 677-684
        • Hayreh SS
        • Podhajsky P
        • Zimmerman MB
        Beta-blocker eyedrops and nocturnal arterial hypotension.
        Am J Ophthalmol. 1999; 128: 301-309
        • van der Valk R
        • Webers CA
        • Schouten JS
        • et al.
        Intraocular pressure-lowering effects of all commonly used glaucoma drugs: A meta-analysis of randomized clinical trials.
        Ophthalmology. 2005; 112: 1177-1185
        • Cheng JW
        • Cai JP
        • Wei RL
        Meta-analysis of medical intervention for normal tension glaucoma.
        Ophthalmology. 2009; 116: 1243-1249
        • Serle JB
        • Katz LJ
        • McLaurin E
        • et al.
        Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (rocket-1 and rocket-2).
        Am J Ophthalmol. 2018; 186: 116-127
        • Weinreb RN
        • Ong T
        • Scassellati Sforzolini B
        • et al.
        A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: The voyager study.
        Br J Ophthalmol. 2015; 99: 738-745
        • Weinreb RN
        • Scassellati Sforzolini B
        • Vittitow J
        • Liebmann J
        Latanoprostene bunod 0.024% versus timolol maleate 0.5% in subjects with open-angle glaucoma or ocular hypertension: The apollo study.
        Ophthalmology. 2016; 123: 965-973
        • Medeiros FA
        • Martin KR
        • Peace J
        • et al.
        Comparison of latanoprostene bunod 0.024% and timolol maleate 0.5% in open-angle glaucoma or ocular hypertension: The lunar study.
        Am J Ophthalmol. 2016; 168: 250-259
        • Liu JHK
        • Slight JR
        • Vittitow JL
        • et al.
        Efficacy of latanoprostene bunod 0.024% compared with timolol 0.5% in lowering intraocular pressure over 24 hours.
        Am J Ophthalmol. 2016; 169: 249-257
      6. Aerie Pharmaceuticals Inc. Rhopressa (netarsudil ophthalmic solution) [package insert]. U.S. Food and Drug Administration website. Revised December 2017.

        • Bhorade AM
        • Wilson BS
        • Gordon MO
        • et al.
        The utility of the monocular trial: Data from the ocular hypertension treatment study.
        Ophthalmology. 2010; 117: 2047-2054
        • Realini TD
        A prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.
        Ophthalmology. 2009; 116: 1237-1242
        • Piltz J
        • Gross R
        • Shin DH
        • et al.
        Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.
        Am J Ophthalmol. 2000; 130: 441-453
        • Realini T
        • Fechtner RD
        • Atreides SP
        • Gollance S
        The uniocular drug trial and second-eye response to glaucoma medications.
        Ophthalmology. 2004; 111: 421-426
        • Robin AL
        • Covert D
        Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?.
        Ophthalmology. 2005; 112: 863-868
        • Robin AL
        • Novack GD
        • Covert DW
        • et al.
        Adherence in glaucoma: Objective measurements of once-daily and adjunctive medication use.
        Am J Ophthalmol. 2007; 144: 533-540
        • Zimmerman TJ
        • Kooner KS
        • Kandarakis AS
        • Ziegler LP
        Improving the therapeutic index of topically applied ocular drugs.
        Arch Ophthalmol. 1984; 102: 551-553
        • Nordstrom BL
        • Friedman DS
        • Mozaffari E
        • et al.
        Persistence and adherence with topical glaucoma therapy.
        Am J Ophthalmol. 2005; 140: 598-606
        • Friedman DS
        • Quigley HA
        • Gelb L
        • et al.
        Using pharmacy claims data to study adherence to glaucoma medications: Methodology and findings of the glaucoma adherence and persistency study (GAPS).
        Invest Ophthalmol Vis Sci. 2007; 48: 5052-5057
        • Schwartz GF
        • Reardon G
        • Mozaffari E
        Persistency with latanoprost or timolol in primary open-angle glaucoma suspects.
        Am J Ophthalmol. 2004; 137: S13-S16
        • Okeke CO
        • Quigley HA
        • Jampel HD
        • et al.
        Adherence with topical glaucoma medication monitored electronically the travatan dosing aid study.
        Ophthalmology. 2009; 116: 191-199
        • Tsai JC
        A comprehensive perspective on patient adherence to topical glaucoma therapy.
        Ophthalmology. 2009; 116: S30-S36
        • Stone JL
        • Robin AL
        • Novack GD
        • et al.
        An objective evaluation of eyedrop instillation in patients with glaucoma.
        Arch Ophthalmol. 2009; 127: 732-736
        • Aptel F
        • Masset H
        • Burillon C
        • et al.
        The influence of disease severity on quality of eye-drop administration in patients with glaucoma or ocular hypertension [letter].
        Br J Ophthalmol. 2009; 93: 700-701
        • Osterberg L
        • Blaschke T
        Adherence to medication.
        N Engl J Med. 2005; 353: 487-497
        • Waterman H
        • Evans JR
        • Gray TA
        • et al.
        Interventions for improving adherence to ocular hypotensive therapy.
        Cochrane Database Syst Rev. 2013; CD006132
        • Moore DB
        • Walton C
        • Moeller KL
        • et al.
        Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: A patient survey.
        BMC Ophthalmol. 2014; 14: 79
      7. Department of Health & Human Services Centers for Medicare & Medicaid Services. Early refill edits on topical ophthalmic products [memorandum]. June 2, 2010.

        • Perera SA
        • Ting DS
        • Nongpiur ME
        • et al.
        Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an asian population.
        Clin Ophthalmol. 2016; 10: 757-764
        • Brandt JD
        • DuBiner HB
        • Benza R
        • et al.
        Long-term safety and efficacy of a sustained-release bimatoprost ocular ring.
        Ophthalmology. 2017; 124: 1565-1566
        • Gote V
        • Sikder S
        • Sicotte J
        • Pal D
        Ocular drug delivery: Present innovations and future challenges.
        J Pharmacol Exp Ther. 2019; 370: 602-624
        • Wong TT
        • Novack GD
        • Natarajan JV
        • et al.
        Nanomedicine for glaucoma: Sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops.
        Drug Deliv Transl Res. 2014; 4: 303-309
        • Gutierrez-Hernandez JC
        • Caffey S
        • Abdallah W
        • et al.
        One-year feasibility study of replenish micropump for intravitreal drug delivery: A pilot study.
        Transl Vis Sci Technol. 2014; 3: 8
        • Craven ER
        • Walters T
        • Christie WC
        • et al.
        24-month phase i/ii clinical trial of bimatoprost sustained-release implant (bimatoprost sr) in glaucoma patients.
        Drugs. 2020; 80: 167-179
        • Dick HB
        • Schultz T
        • Gerste RD
        Miniaturization in glaucoma monitoring and treatment: A review of new technologies that require a minimal surgical approach.
        Ophthalmol Ther. 2019; 8: 19-30
      8. Allergan, Inc. Durysta (bimatoprost implant) [drug approval] u.S. Food and Drug Administration website. Revised March 2020.

        • Brauner SC
        • Chen TC
        • Hutchinson BT
        • et al.
        The course of glaucoma during pregnancy: A retrospective case series.
        Arch Ophthalmol. 2006; 124: 1089-1094
        • Johnson SM
        • Martinez M
        • Freedman S
        Management of glaucoma in pregnancy and lactation.
        Surv Ophthalmol. 2001; 45: 449-454
        • Razeghinejad MR
        • Tania Tai TY
        • Fudemberg SJ
        • Katz LJ
        Pregnancy and glaucoma.
        Surv Ophthalmol. 2011; 56: 324-335
        • Salim S
        Glaucoma in pregnancy.
        Curr Opin Ophthalmol. 2014; 25: 93-97
        • U.S. Food and Drug Administration Center for Drug Evaluation and Research
        FDA background package for meeting of drug safety and risk management advisory committee (DSaRM): Management of drug related teratogenic risk - Day one. December 12, 2012:11-13.